Skip to main content
Caplight Logo









RoEx

RoEx

Private
LondonMedia, Entertainment & Gaminghttps://roexaudio.com

Last Round

Grant

May 2, 2024

Total Funding Raised

$310,000

Company Overview

RoEx operates in Media, Entertainment & Gaming and is based in London. Its latest recorded funding round was a Grant round in May 2024.

RoEx is a music technology company that develops AI-powered audio production tools, including automated mixing and mastering software for musicians and content creators.

Sector

Media, Entertainment & Gaming

Verticals

Content Creation, Creator Economy, API Management

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

RoEx Comparables

Compare RoEx with similar companies based on industry and business-model similarity.

RoEx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Masterchannel
89%
Cryo Mix
83%
Beat Shaper
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

RoEx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 2, 2024
Pre SeedJan 12, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

David Ronan

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

RoEx Investors

Notable investors and investment history

RoEx investors
InvestorRounds
Innovate UKGrant
HaatchPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 4, 2025

    Monthly visitors increased 32% MoM.

  • May 1, 2025

    Monthly visitors grew 33% MoM, reaching 104.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

RoEx Filings

Explore SEC and related filing metadata, where available.

RoEx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about RoEx's valuation, stock price, and market status.

Is RoEx a public or private company?

RoEx is a private company.

What is the current stock price of RoEx?

RoEx is a private company, so its shares have no public market price. Caplight tracks RoEx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RoEx worth (valuation)?

Valuation information for RoEx is not publicly available.

Can I buy RoEx stock?

RoEx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RoEx's last funding round?

RoEx's most recent funding round was Grant on May 2, 2024.

Who are the main investors in RoEx?

Key investors in RoEx include Innovate UK, Haatch.

Will RoEx IPO soon?

No public IPO plans have been announced for RoEx.

How can I track RoEx secondary market activity?

Caplight tracks bids, offers, and trades in RoEx's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2022
Last FundingMay 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?